Filter
2506
Filtered Results: 2506
Text search:
drug
trial
Featured
Recommendations
231
New Publications
500
Language
Document type
No document type
1498
Guidelines
387
Studies & Reports
376
Manuals
100
Strategic & Response Plan
52
Fact sheets
40
Training Material
22
Situation Updates
13
Infographics
8
Resource Platforms
6
Brochures
3
App
1
Countries / Regions
India
145
Global
87
South Africa
63
Western and Central Europe
55
Kenya
43
Nigeria
39
Ethiopia
38
Africa
37
Uganda
36
Eastern Europe
29
Liberia
29
Zambia
28
Malawi
27
Tanzania
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
21
Zimbabwe
20
Latin America and the Carribbean
20
Rwanda
19
Asia
18
Philippines
17
Bangladesh
17
Myanmar / Burma
16
South–East Asia Region
15
Brazil
14
East and Southern Africa
13
Namibia
13
Colombia
11
Lesotho
11
Mozambique
11
Cambodia
11
West and Central Africa
11
Germany
10
USA
9
Middle East and North Africa
9
South Sudan
9
Indonesia
9
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Thailand
6
Syria
6
Cameroon
5
Albania
5
Senegal
5
Guinea
5
Eastern Europe and Central Asia
5
Laos
4
Burkina Faso
4
Venezuela
4
Argentina
4
Vietnam
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Poland
2
Iraq
2
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Mali
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
685
Clinical Guidelines
336
Public Health
138
Women & Child Health
100
Pharmacy & Technologies
29
Key Resources
24
Capacity Building
19
Toolboxes
HIV
344
Mental Health
339
TB
298
COVID-19
162
NTDs
116
AMR
89
NCDs
77
Pharmacy
72
Ebola
57
Rapid Response
34
Caregiver
30
Refugee
28
Planetary Health
25
Disability
24
Global Health Education
16
Conflict
14
Health Financing Toolbox
12
Polio
9
Social Ethics
7
Specific Hazards
5
Natural Hazards
5
Cholera
5
Zika
3
Health Financing
1
Extreme heat events (EHEs) are a leading cause of weather-related injury and death in the United States, and under a changing climate, these meteorological episodes are predicted to increase in both frequency and intensity. Prolonged heat exposure from EHEs places an increased strain on the heart an...
In emergency or humanitarian settings, mobile clinics are used to bring essential lifesaving health care to communities affected by crises. Though there are standard emergency benefit packages for health services during emergencies, there are however no agreed or standard way of running mobile clini...
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Cancer in sub-Saharan Africa
recommended
Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality.
Without rapid interventions, data estimates show a major increase in cancer mo...
Consultancy Report May 2022
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent disruption to health system functioning, reconstruction of the health system is integral to the country...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
